Combination of Aspirin and an Anti-Clotting Drug Reduces Risk of Dialysis Access Failure – 3
Narrator: This is NIH Health Matters. Researchers have made an important step for physicians who care for people who need kidney replacement therapy. A study shows the drug combination of dipyyridomole and aspirin can extend the life of access grafts used for dialysis.
Dr. Meyers: We have a pretty good notion of how drugs like dipyridamole and aspirin work on the access.
Narrator: Dr. Catherine Meyers at the National Institute of Diabetes and Digestive and Kidney Diseases says of the study:
Dr. Meyers: Itís given us a large trial with a significant effect, although itís a modest effect, but itís still is the only therapy that we have demonstrated at this point.
Narrator: New therapies may have even larger impact on outcomes in grafts. For more, visit www.nih.gov. Health Matters is produced by the National Institutes of Health, part of the US Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.